Evaluating Manufacturing to Balance Scientific Rigor & Commercial Scalability

• Building robust, well-understood processes early to enable reliable and efficient scale-up
• Anticipating technical, cost, and operational constraints that may hinder translation from clinical manufacturing to commercial manufacturing
• Maintaining consistent, adaptable manufacturing and analytical systems from early trials to commercial production

Speakers:

Lavakumar Karyampudi

Senior Director, Cell Therapies

Moffitt Cancer Center